Symbiotec Pharmalab IPO Subscription Status
Symbiotec Pharmalab IPO was subscribed 75.08 times in total: QIB 181.2x, NII 77.56x and retail 13.69x. A retail application for one lot has about a 1 in 14 chance of allotment.
Subscription by category
| Category | Shares offered | Shares bid | Subscription |
|---|
| QIB | – | – | 181.2x |
| NII | – | – | 77.56x |
| Retail | – | – | 13.69x |
| Employee | – | – | 16.32x |
| Total | – | – | 75.08x |
Key facts
| Item | Detail |
|---|
| Segment | Mainboard |
| Status | Listed |
| Price band | ₹938–988 |
| Lot size | 15 shares |
| Minimum investment | ₹14,820 |
| Issue size | ₹1,757 crore |
| Opens | 24 August 2026 |
| Closes | 27 August 2026 |
| Allotment | 28 August 2026 |
| Listing | 1 September 2026 |
| Listing at | NSE, BSE |
| Registrar | MUFG Intime India Pvt Ltd (formerly Link Intime) |
More on the Symbiotec Pharmalab IPO
